TFS
EW icon

TrustCore Financial Services’s Edwards Lifesciences EW Stock Holding History

TrustCore Financial Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-125
Closed -$12K – 1089
2022
Q2 		$12K Buy
+125
New +$12.9K ﹤0.01% 719
2021
Q1 		– Sell
-90
Closed -$8K – 941
2020
Q4 		$8K Buy
+90
New +$7.46K ﹤0.01% 712

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TrustCore Financial Services's EW Position: Q3 2022 in Review

TrustCore Financial Services sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 125 shares — an estimated $12K sold.

TrustCore Financial Services first reported a position in EW in Q4 2020 and held it in 2 quarters. The position peaked at $12K in Q2 2022. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • TrustCore Financial Services reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 125 Edwards Lifesciences shares in Q3 2022, an estimated $12K.
  • TrustCore Financial Services first reported a position in Edwards Lifesciences in Q4 2020 and held it in 2 quarters.
  • TrustCore Financial Services's Edwards Lifesciences position peaked at $12K in Q2 2022.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on TrustCore Financial Services's 13F filing for Q3 2022, filed 3 Nov 2022.